Patents
Barr Confirms Patent Challenge of Xopenex Inhalation Solution, 0.31mg/3mL, 0.63mg/3mL and 1.25mg/3mL
Published in Medical Letter on the CDC and FDA, August 5th, 2007
Barr filed its Abbreviated New Drug Application (ANDA) containing a paragraph IV certification for a generic Xopenex product with the U.S. Food & Drug Administration (FDA) in March 2007, and received notification of the application's acceptance for filing in May 2007. Following receipt of the notice from the FDA, Barr notified Sepracor, the New Drug Application (NDA) and patent owner.
On...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Flu Vaccines
Universal flu vaccine being tested on humans - Heart Disease
New Review Adds More Reasons to Avoid Diabetes Drug Avandia - HIV/AIDS Co-Infection
New publication presents latest in HIV/TB treatment, research - Obesity and Diabetes
Overweight Children: An Emerging Epidemic - Alzheimer Disease
Cortex to Resume Clinical Trial with AMPAKINE CX717 in Alzheimer-PET Scan Study after FDA Approves Protocol with Higher Doses of Drug - Amyotrophic Lateral Sclerosis
Avicena to Proceed to Confirmatory Phase III Amyotrophic Lateral Sclerosis (ALS) Trial - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
